What is raloxifene?
Raloxifene is a drug, taken by mouth as a pill. In December 1997, it was approved by the FDA for the prevention of osteoporosis in postmenopausal women. Raloxifene is being studied because large studies testing its effectiveness against osteoporosis have shown that women taking the drug developed fewer breast cancers than women taking a placebo. One of these studies was the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. The MORE Trial was designed to study the effects of raloxifene on osteoporosis in postmenopausal women. Researchers also tracked rates of breast cancer and observed a reduction in the risk of breast cancer among women who took raloxifene. The results of this study were reported in the June 16, 1999, issue of the Journal of the American Medical Association.